Cargando…
Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation
The worldwide prevalence of metabolic syndrome, which includes obesity and its associated diseases, is rising rapidly. The human gut microbiome is recognized as an independent environmental modulator of host metabolic health and disease. Research in animal models has demonstrated that the gut microb...
Autores principales: | Marotz, Clarisse A., Zarrinpar, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045147/ https://www.ncbi.nlm.nih.gov/pubmed/27698622 |
Ejemplares similares
-
Fecal microbiota transplantation in cancer management: Current status and perspectives
por: Chen, Danfeng, et al.
Publicado: (2018) -
Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome—A Systematic Review
por: Zhang, Zhengxiao, et al.
Publicado: (2019) -
Fecal microbiota transplantation in metabolic syndrome: History, present and future
por: de Groot, P. F., et al.
Publicado: (2017) -
Treating the Metabolic Syndrome by Fecal Transplantation—Current Status
por: Malnick, Stephen D. H., et al.
Publicado: (2021) -
Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism
por: Zarrinpar, Amir, et al.
Publicado: (2018)